bandage retention cohesive heavy (Coban 1584)
What to know about bandage retention cohesive heavy — also sold as Coban 1584, Peg 7420, Peg 7422, Peg 7423, Peg 7425: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
bandage retention cohesive heavy (brand names: Coban 1584, Peg 7420, Peg 7422, Peg 7423, Peg 7425) is classified as Minimal risk by AllMeds. Medical auxiliary product with no pharmacological risk.
Key Takeaways
- Risk level: Minimal (0 points)
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | PBS listed |
Risk Profile
Medical auxiliary product with no pharmacological risk.
How bandage retention cohesive heavy is regulated
bandage retention cohesive heavy is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Check this medication against your full medication list
Run a full risk assessment including bandage retention cohesive heavy interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.